MYCN and neuroblastoma: However, even in some MYCN-amplified BETi-sensitive neuroblastoma lines, a portion of cells survive the treatment, as documented by the Emax values (range: 55–100%), with some MYCN-amplified lines described as BETi-resistant [48].